戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 linical trials due to dose-limiting toxicity when administered systemically.
2  mouse susceptibility to C. jejuni infection when administered systemically.
3  carrageenan- or FCA-induced pain in rodents when administered systemically.
4 linically is limited by serious side effects when administered systemically.
5 ical responses to noxious stimuli in rodents when administered systemically.
6 f TNF has been severe dose-limiting toxicity when administered systemically.
7 apable of inducing strong antitumor activity when administered systemically.
8 mour inflammatory cytokines are highly toxic when administered systemically.
9 tic payloads which are otherwise ineffective when administered systemically.
10 ghlighting their biocompatibility and safety when administered systemically.
11 g radioisotopes and toxic drugs (ineffective when administered systemically alone)--are becoming a si
12 ach will require chimeras that are effective when administered systemically and are amenable to chemi
13                                              When administered systemically, anti-TTR siRNAs alleviat
14 istribution of cytoplasmic reporter proteins when administered systemically as fusion proteins or cro
15 onal cell loss and gliosis in wild-type mice when administered systemically before or up to 6 h after
16 atic and liver injury and liver inflammation when administered systemically, but not intratracheally.
17                                     However, when administered systemically by i.v. bolus, ATI-2341 a
18 the airways by the intranasal route, but not when administered systemically by the intraperitoneal ro
19 was markedly reduced compared with ascomycin when administered systemically due to more rapid clearan
20                                              When administered systemically, EVs are taken up and seq
21                                              When administered systemically (i.v.), B4-27 suppressed
22                                              When administered systemically in mice, adenovirus vecto
23 a CCR2-silencing short interfering RNA that, when administered systemically in mice, show rapid blood
24                                              When administered systemically in mouse antinociceptive
25                                              When administered systemically in mouse models of skin g
26 aria, and enhanced trabecular bone formation when administered systemically in vivo.
27 nificantly stabilizing or reversing symptoms when administered systemically into female RTT mice.
28  members are toxic to normal mammalian cells when administered systemically, only a few TNF family me
29 ocaine-evoked premature responses in 5-CSRTT when administered systemically or directly into VTA.
30 l cultures and protected against IBV in vivo when administered systemically or intranasally.
31 ant increases in bone mass and bone strength when administered systemically or locally to the skeleto
32 However, insulin is also an anabolic factor; when administered systemically, pharmacological levels o
33                                              When administered systemically, PHF1 has been shown to m
34                                              When administered systemically, PL2-displaying recombina
35                                              When administered systemically, RTC13 was shown to parti
36                                     However, when administered systemically, they cause serious adver
37                                              When administered systemically to ambulant animals, amph
38                                              When administered systemically to mice subjected to SCI,
39                                              When administered systemically to mice, HTiO2 NPs effect
40                                              When administered systemically to mice, the proteasome i
41 ts on energy balance and insulin sensitivity when administered systemically to rodents with diet-indu
42 rm of fibronectin is strongly antimetastatic when administered systemically to tumor-bearing mice.